{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:08:43Z","timestamp":1784740123018,"version":"3.55.0"},"reference-count":15,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,14]]},"DOI":"10.14797\/mdcvj.1071","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T11:11:23Z","timestamp":1647256283000},"page":"73-77","source":"Crossref","is-referenced-by-count":6,"title":["Future Directions in Cardiac Amyloidosis"],"prefix":"10.14797","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-9565","authenticated-orcid":false,"given":"Barry","family":"Trachtenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"3","key":"key20220314071115_B1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jacc.2019.03.012","article-title":"Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy","volume":"74","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220314071115_B2","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1038\/s41467-021-22876-9","article-title":"A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy","volume":"12","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"key20220314071115_B3","article-title":"It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis","volume":"18","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"3","key":"key20220314071115_B4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjcard.2011.03.069","article-title":"Relation of Clinical, Echocardiographic and Electrocardiographic Features of Cardiac Amyloidosis to the Presence of the Transthyretin V122I Allele in Older African-American Men","volume":"108","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"key20220314071115_B5","article-title":"Cardiac Amyloidosis Treatment","volume":"18","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"key20220314071115_B6","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine; c 2021. A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis; 2017 Nov 8 [cited 2021 Dec 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03336580"},{"key":"key20220314071115_B7","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine; c 2021. First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy; 2020 Apr 24 [cited 2021 Dec 10]. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04360434"},{"issue":"6","key":"key20220314071115_B8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CCRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"issue":"25","key":"key20220314071115_B9","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jacc.2016.03.593","article-title":"Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure","volume":"67","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220314071115_B10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","year":"2021","journal-title":"New Engl J Med"},{"issue":"5","key":"key20220314071115_B11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41408-020-0321-6","article-title":"Venetoclax for the treatment of translocation (11;14) AL amyloidosis","volume":"10","year":"2020","journal-title":"Blood Cancer J"},{"key":"key20220314071115_B12","article-title":"Cael-101 is well-tolerated In Al Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (Cybord): A Phase 2 Dose-Finding Study (Nct04304144)"},{"key":"key20220314071115_B13","article-title":"Targeted treatments of of AL and ATTR amyloidosis","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"3","key":"key20220314071115_B14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41375-018-0370-z","article-title":"Comparative analysis of staging systems in AL amyloidosis","volume":"33","year":"2019","journal-title":"Leukemia"},{"issue":"29","key":"key20220314071115_B15","first-page":"E6741","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","year":"2018","journal-title":"PNAS"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T11:11:40Z","timestamp":1647256300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1071\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,14]]}},"alternative-id":["10.14797\/mdcvj.1071"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1071","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}